US Stock MarketDetailed Quotes

BBIO BridgeBio Pharma

Watchlist
  • 26.490
  • +0.280+1.07%
Close Dec 20 16:00 ET
  • 26.490
  • 0.0000.00%
Post 20:01 ET
5.01BMarket Cap-10.95P/E (TTM)

BridgeBio Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-33.22%2.73M
32.11%2.17M
11,461.88%211.12M
-88.02%9.3M
-6.68%1.75M
1,110.36%4.09M
-97.77%1.64M
7.79%1.83M
11.38%77.65M
-85.49%1.87M
Operating revenue
-33.22%2.73M
32.11%2.17M
11,461.88%211.12M
-88.02%9.3M
-6.68%1.75M
1,110.36%4.09M
-97.77%1.64M
7.79%1.83M
11.38%77.65M
-85.49%1.87M
Cost of revenue
0.00%598K
-0.17%598K
-8.14%598K
-28.77%2.45M
-7.57%598K
-19.08%598K
-14.43%599K
-51.71%651K
10.28%3.43M
-58.28%647K
Gross profit
-38.91%2.13M
50.67%1.57M
17,816.77%210.52M
-90.76%6.86M
-6.21%1.15M
971.07%3.49M
-98.57%1.04M
239.60%1.18M
11.43%74.21M
-89.21%1.22M
Operating expense
17.62%189.26M
21.31%174.22M
66.80%206.78M
11.73%606.3M
44.84%177.81M
30.08%160.91M
-0.84%143.61M
-18.10%123.97M
-15.64%542.65M
-30.62%122.76M
Selling and administrative expenses
92.36%68.82M
64.78%59.52M
111.54%65.81M
5.17%150.59M
49.34%47.58M
14.71%35.78M
-0.83%36.12M
-28.84%31.11M
-25.50%143.19M
-41.80%31.86M
Research and development costs
-3.75%120.44M
6.70%114.7M
51.81%140.97M
14.08%455.71M
43.26%130.23M
35.27%125.14M
-0.84%107.49M
-13.74%92.86M
-11.43%399.46M
-25.61%90.9M
Operating profit
-18.87%-187.13M
-21.10%-172.65M
103.05%3.74M
-27.97%-599.44M
-45.35%-176.66M
-26.85%-157.42M
-98.62%-142.57M
18.69%-122.79M
18.76%-468.44M
26.61%-121.54M
Net non-operating interest income expense
-19.69%-19.77M
-10.34%-17.74M
-21.47%-19.4M
13.23%-63.25M
7.60%-14.69M
5.14%-16.51M
17.59%-16.08M
20.47%-15.97M
-59.70%-72.9M
-6.33%-15.9M
Non-operating interest income
-13.10%3.3M
15.09%5.2M
-1.88%4.08M
139.17%18.04M
36.31%5.58M
56.93%3.79M
489.30%4.51M
1,455.43%4.15M
565.67%7.54M
2,148.35%4.09M
Non-operating interest expense
13.57%23.06M
11.38%22.94M
16.65%23.47M
1.06%81.29M
1.39%20.27M
2.43%20.31M
1.55%20.59M
-1.10%20.12M
71.96%80.44M
32.09%19.99M
Other net income (expense)
867.60%42.64M
5,688.61%114.85M
-416.55%-20.51M
-83.34%9.44M
771.48%21.02M
-522.43%-5.56M
-102.32%-2.06M
86.87%-3.97M
58.23%56.68M
-111.07%-3.13M
Gain on sale of security
----
----
----
323.17%18.3M
----
----
113.51%1.4M
----
---8.2M
----
Earnings from equity interest
---6.56M
---7.93M
----
----
----
--0
--0
----
----
----
Special income (charges)
985.74%49.2M
3,563.69%122.3M
-790.18%-29.99M
81.77%-9.13M
227.08%2.45M
-522.43%-5.56M
57.94%-3.53M
88.86%-3.37M
-239.76%-50.07M
-106.83%-1.93M
-Less：Restructuring and merger&acquisition
1,598.90%4.62M
-18.13%2.89M
-7.12%3.13M
-74.47%7.93M
-90.20%754K
-94.50%272K
-57.94%3.53M
-66.34%3.37M
--31.05M
--7.69M
-Less:Impairment of capital assets
--0
--0
--271K
--0
--0
--0
--0
--0
--12.72M
--0
-Less:Other special charges
----
----
--26.59M
----
----
----
----
----
----
----
-Gain on sale of business
--52.03M
--125.19M
----
---1.2M
---1.2M
--0
--0
----
----
----
-Gain on sale of property,plant,equipment
134.01%1.8M
----
----
----
----
-183.45%-5.28M
----
----
-117.59%-6.3M
-79.64%5.76M
Other non- operating income (expenses)
----
515.79%468K
1,677.87%9.48M
-99.77%270K
----
----
-99.93%76K
---601K
--114.95M
--7M
Income before tax
8.49%-164.25M
52.99%-75.54M
74.67%-36.16M
-34.79%-653.25M
-21.17%-170.33M
-28.03%-179.49M
-6,179.91%-160.7M
29.11%-142.73M
17.36%-484.65M
7.69%-140.57M
Income tax
Net income
8.49%-164.25M
52.99%-75.54M
74.67%-36.16M
-34.79%-653.25M
-21.17%-170.33M
-28.03%-179.49M
-6,179.91%-160.7M
29.11%-142.73M
17.36%-484.65M
7.69%-140.57M
Net income continuous Operations
8.49%-164.25M
52.99%-75.54M
74.67%-36.16M
-34.79%-653.25M
-21.17%-170.33M
-28.03%-179.49M
-6,179.91%-160.7M
29.11%-142.73M
17.36%-484.65M
7.69%-140.57M
Minority interest income
11.05%-2.21M
25.53%-2.09M
63.35%-944K
-189.68%-10.05M
26.82%-2.18M
12.79%-2.49M
-138.43%-2.8M
47.78%-2.58M
85.49%-3.47M
41.65%-2.98M
Net income attributable to the parent company
8.45%-162.04M
53.48%-73.46M
74.87%-35.22M
-33.67%-643.2M
-22.21%-168.15M
-28.88%-177M
-1,502.06%-157.9M
28.64%-140.16M
14.46%-481.18M
6.51%-137.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.45%-162.04M
53.48%-73.46M
74.87%-35.22M
-33.67%-643.2M
-22.21%-168.15M
-28.88%-177M
-1,502.06%-157.9M
28.64%-140.16M
14.46%-481.18M
6.51%-137.59M
Basic earnings per share
20.37%-0.86
60.20%-0.39
78.26%-0.2
-21.17%-3.95
-4.35%-0.96
-16.13%-1.08
-1,300.00%-0.98
31.85%-0.92
16.41%-3.26
8.91%-0.92
Diluted earnings per share
20.37%-0.86
60.20%-0.39
78.26%-0.2
-21.17%-3.95
-4.35%-0.96
-16.13%-1.08
-1,300.00%-0.98
31.85%-0.92
16.41%-3.26
8.91%-0.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -33.22%2.73M32.11%2.17M11,461.88%211.12M-88.02%9.3M-6.68%1.75M1,110.36%4.09M-97.77%1.64M7.79%1.83M11.38%77.65M-85.49%1.87M
Operating revenue -33.22%2.73M32.11%2.17M11,461.88%211.12M-88.02%9.3M-6.68%1.75M1,110.36%4.09M-97.77%1.64M7.79%1.83M11.38%77.65M-85.49%1.87M
Cost of revenue 0.00%598K-0.17%598K-8.14%598K-28.77%2.45M-7.57%598K-19.08%598K-14.43%599K-51.71%651K10.28%3.43M-58.28%647K
Gross profit -38.91%2.13M50.67%1.57M17,816.77%210.52M-90.76%6.86M-6.21%1.15M971.07%3.49M-98.57%1.04M239.60%1.18M11.43%74.21M-89.21%1.22M
Operating expense 17.62%189.26M21.31%174.22M66.80%206.78M11.73%606.3M44.84%177.81M30.08%160.91M-0.84%143.61M-18.10%123.97M-15.64%542.65M-30.62%122.76M
Selling and administrative expenses 92.36%68.82M64.78%59.52M111.54%65.81M5.17%150.59M49.34%47.58M14.71%35.78M-0.83%36.12M-28.84%31.11M-25.50%143.19M-41.80%31.86M
Research and development costs -3.75%120.44M6.70%114.7M51.81%140.97M14.08%455.71M43.26%130.23M35.27%125.14M-0.84%107.49M-13.74%92.86M-11.43%399.46M-25.61%90.9M
Operating profit -18.87%-187.13M-21.10%-172.65M103.05%3.74M-27.97%-599.44M-45.35%-176.66M-26.85%-157.42M-98.62%-142.57M18.69%-122.79M18.76%-468.44M26.61%-121.54M
Net non-operating interest income expense -19.69%-19.77M-10.34%-17.74M-21.47%-19.4M13.23%-63.25M7.60%-14.69M5.14%-16.51M17.59%-16.08M20.47%-15.97M-59.70%-72.9M-6.33%-15.9M
Non-operating interest income -13.10%3.3M15.09%5.2M-1.88%4.08M139.17%18.04M36.31%5.58M56.93%3.79M489.30%4.51M1,455.43%4.15M565.67%7.54M2,148.35%4.09M
Non-operating interest expense 13.57%23.06M11.38%22.94M16.65%23.47M1.06%81.29M1.39%20.27M2.43%20.31M1.55%20.59M-1.10%20.12M71.96%80.44M32.09%19.99M
Other net income (expense) 867.60%42.64M5,688.61%114.85M-416.55%-20.51M-83.34%9.44M771.48%21.02M-522.43%-5.56M-102.32%-2.06M86.87%-3.97M58.23%56.68M-111.07%-3.13M
Gain on sale of security ------------323.17%18.3M--------113.51%1.4M-------8.2M----
Earnings from equity interest ---6.56M---7.93M--------------0--0------------
Special income (charges) 985.74%49.2M3,563.69%122.3M-790.18%-29.99M81.77%-9.13M227.08%2.45M-522.43%-5.56M57.94%-3.53M88.86%-3.37M-239.76%-50.07M-106.83%-1.93M
-Less：Restructuring and merger&acquisition 1,598.90%4.62M-18.13%2.89M-7.12%3.13M-74.47%7.93M-90.20%754K-94.50%272K-57.94%3.53M-66.34%3.37M--31.05M--7.69M
-Less:Impairment of capital assets --0--0--271K--0--0--0--0--0--12.72M--0
-Less:Other special charges ----------26.59M----------------------------
-Gain on sale of business --52.03M--125.19M-------1.2M---1.2M--0--0------------
-Gain on sale of property,plant,equipment 134.01%1.8M-----------------183.45%-5.28M---------117.59%-6.3M-79.64%5.76M
Other non- operating income (expenses) ----515.79%468K1,677.87%9.48M-99.77%270K---------99.93%76K---601K--114.95M--7M
Income before tax 8.49%-164.25M52.99%-75.54M74.67%-36.16M-34.79%-653.25M-21.17%-170.33M-28.03%-179.49M-6,179.91%-160.7M29.11%-142.73M17.36%-484.65M7.69%-140.57M
Income tax
Net income 8.49%-164.25M52.99%-75.54M74.67%-36.16M-34.79%-653.25M-21.17%-170.33M-28.03%-179.49M-6,179.91%-160.7M29.11%-142.73M17.36%-484.65M7.69%-140.57M
Net income continuous Operations 8.49%-164.25M52.99%-75.54M74.67%-36.16M-34.79%-653.25M-21.17%-170.33M-28.03%-179.49M-6,179.91%-160.7M29.11%-142.73M17.36%-484.65M7.69%-140.57M
Minority interest income 11.05%-2.21M25.53%-2.09M63.35%-944K-189.68%-10.05M26.82%-2.18M12.79%-2.49M-138.43%-2.8M47.78%-2.58M85.49%-3.47M41.65%-2.98M
Net income attributable to the parent company 8.45%-162.04M53.48%-73.46M74.87%-35.22M-33.67%-643.2M-22.21%-168.15M-28.88%-177M-1,502.06%-157.9M28.64%-140.16M14.46%-481.18M6.51%-137.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.45%-162.04M53.48%-73.46M74.87%-35.22M-33.67%-643.2M-22.21%-168.15M-28.88%-177M-1,502.06%-157.9M28.64%-140.16M14.46%-481.18M6.51%-137.59M
Basic earnings per share 20.37%-0.8660.20%-0.3978.26%-0.2-21.17%-3.95-4.35%-0.96-16.13%-1.08-1,300.00%-0.9831.85%-0.9216.41%-3.268.91%-0.92
Diluted earnings per share 20.37%-0.8660.20%-0.3978.26%-0.2-21.17%-3.95-4.35%-0.96-16.13%-1.08-1,300.00%-0.9831.85%-0.9216.41%-3.268.91%-0.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List